GFO Companies — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Shift Labsshiftlabs.com in 𝕏Mar 2023Acquired

Shift Labs develops DripAssist, an FDA-cleared infusion rate monitor that enables safe delivery of gravity IV medications in home and out-of-hospital settings.

Digital HealthHardwareHealthtechMedical DevicesSeattle, US

Beth Kolko(CEO)inJoseph Mechlinski(Executive Officer, Director)Koji Intlekofer(CTO)in

Co-investorsKnockout Capital SGH Capital Y Combinator Great Oaks Venture Capital Investo Capital Lin, Bill | A10 Ventures +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.